Modulation of Nanostructure-Based Lipopolysaccharide Active Immunotherapy in Cancer: Size and Composition Determine Short- and Long-Term Tolerability
Article in Molecular Pharmaceutics (September 2019)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto
Article in Therapeutic Delivery (March 2019)
Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae
Article in The Journal of Antibiotics (July 2016)